David Grainger is a UK biotech investor, and has founded, led or invested in a series of multi-billion pound companies. He is the co-founder of investment firm Medixci and chair of RxCelerate, a firm applying AI to drug discovery.
1 Article
Subscribe
Subscribe to the City AM newsletter to have our top stories delivered directly to your inbox.
